ArticleAntioxidants (Basel, Switzerland)2022

HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAF

Anna Lisa Furfaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.